{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:story:9378f55f-efca-46ed-8869-89ddb50b9a1b", "type": "composite", "version": "1", "versioncreated": "2026-11-07T20:10:26.867126Z", "firstcreated": "2026-11-07T20:10:26.867126Z", "pubstatus": "usable", "language": "uk", "headline": "Генеральний директор aim ImmunoTech купив акції компанії на 3166 доларів", "description_text": "Гендиректор біофармацевтичної компанії aim ImmunoTech Equels придбав акції власної компанії на суму близько 3166 доларів. Угода зафіксована як інсайдерська операція.", "associations": {"item-0": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:06e67ebc-ca0f-4dd4-bf21-21ee8cc497b3", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-11-07T20:10:37.606682Z", "firstcreated": "2026-11-07T20:10:26.867126Z", "pubstatus": "usable", "urgency": 5, "language": "uk", "headline": "Генеральний директор aim ImmunoTech купив акції компанії на 3166 доларів", "byline": "Тетяна Білик", "located": "Ukraine", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Віндор", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Віндор”. Set rel=canonical to https://vindor.com.ua/finansi/generalnii-direktor-aim-immunotech-kupiv-aktsii-kompanii-na-3166-dolariv/ when publishing on the web.", "description_text": "Гендиректор біофармацевтичної компанії aim ImmunoTech Equels придбав акції власної компанії на суму близько 3166 доларів. Угода зафіксована як інсайдерська операція.", "altids": {"mosaic": "06e67ebc-ca0f-4dd4-bf21-21ee8cc497b3", "story": "9378f55f-efca-46ed-8869-89ddb50b9a1b", "slug": "generalnii-direktor-aim-immunotech-kupiv-aktsii-kompanii-na-3166-dolariv"}, "subject": [{"name": "Economy and business", "rel": "direct", "literal": "economy", "code": "medtop:04000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/04000000"}], "place": [{"name": "Ukraine", "literal": "ua", "code": "UA", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:718505c5-f3bf-40ee-a671-be51effd3e61", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Earnings call transcript: Michael Page Q3 2026 returns to growth as stock slips", "description_text": "Michael Page returns to growth in Q3 2026 but shares slip on cautious outlook", "copyrightholder": "content-media.investing.com", "copyrightnotice": "Earnings call transcript: Michael Page Q3 2026 returns to growth as stock slips", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "718505c5-f3bf-40ee-a671-be51effd3e61"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "RSS source", "licence_verified_at": "2026-11-07T20:10:37.623805Z", "attribution_required": true, "attribution_text": "Earnings call transcript: Michael Page Q3 2026 returns to growth as stock slips", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "content-media.investing.com", "source_url": "https://content-media.investing.com/news/moved_LYNXMPEM4416N_1200_L.jpg", "source_page_url": "https://content-media.investing.com/news/moved_LYNXMPEM4416N_1200_L.jpg", "our_page_url": "https://vindor.com.ua/finansi/generalnii-direktor-aim-immunotech-kupiv-aktsii-kompanii-na-3166-dolariv/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://content-media.investing.com/news/moved_LYNXMPEM4416N_1200_L.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:9378f55f-efca-46ed-8869-89ddb50b9a1b", "slug": "aim-immunotech-3166-20261107", "status": "developing", "languages": ["uk"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Віндор", "canonical_required": true, "canonical_url": "https://vindor.com.ua/finansi/generalnii-direktor-aim-immunotech-kupiv-aktsii-kompanii-na-3166-dolariv/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "single_source", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Матеріал підготовлено за допомогою ШІ під редакційною відповідальністю Haydamax OÜ.", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-11-07T20:10:37.620238Z"}, "sources": [{"url": "https://www.investing.com/news/insider-trading-news/aim-immunotech-ceo-equels-buys-3166-in-company-stock-93CH-5009813", "title": "aim immunoTech CEO Equels buys $3,166 in company stock", "publisher": "investing.com", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-11-07T20:10:37.611048Z", "published_at": "2026-11-07T09:30:58Z"}]}, "wireva:publication": {"name": "Віндор", "domain": "vindor.com.ua", "country": "UA", "url": "https://vindor.com.ua/finansi/generalnii-direktor-aim-immunotech-kupiv-aktsii-kompanii-na-3166-dolariv/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/06e67ebc-ca0f-4dd4-bf21-21ee8cc497b3", "html": "https://wireva.mib.news/item/06e67ebc-ca0f-4dd4-bf21-21ee8cc497b3/generalnii-direktor-aim-immunotech-kupiv-aktsii-kompanii-na-3166-dolariv/", "story": "https://wireva.mib.news/story/aim-immunotech-3166-20261107/"}, "wireva:metrics": {"word_count": 179, "char_count": 1366, "reading_time_seconds": 98}}}}, "extra": {"wireva:languages": ["uk"], "wireva:status": "developing", "wireva:item_count": 1}}